Vos recherches enregistrées
Vous n'avez aucune recherche enregistrée
Rechercher 1 filtre appliqués
Date de notification | Date de transaction | Entreprise | A/V Type de transaction | Initié et/ou titre |
Nb. d'actions Prix Valeur |
Nombre d'actions | Prix | Valeur totale | Détails |
---|---|---|---|---|---|---|---|---|---|
2024-05-03 | 2024-05-02 |
Bctg Acquisition Corp
(BCTG)
|
V Vente |
MVA Investors, LLC See remarks |
75 000
-12.1%
7,56567 000 USD |
75 000 -12.1% | 7,56 | 567 000 USD | |
2024-05-03 | 2024-05-02 | A Achat |
Saba Capital Management, L.P. Actionnaire important |
50 596
+0.9%
11,79596 527 USD |
50 596 +0.9% | 11,79 | 596 527 USD | ||
2024-05-03 | 2024-05-02 |
Edgewise Therapeutics Inc
(EWTX)
|
V Vente |
Carruthers R Michael Chief Financial Officer Dirigeant |
2 157
-5.8%
18,9140 789 USD |
2 157 -5.8% | 18,91 | 40 789 USD | |
2024-05-03 | 2024-05-02 |
Amkor Technology Inc
(AMKR)
|
V Vente |
ROGERS MARK N EVP & General Counsel Dirigeant |
5 000
-16.5%
31,30156 500 USD |
5 000 -16.5% | 31,30 | 156 500 USD | |
2024-05-03 | 2024-05-02 |
Meridian Corp
(MRBK)
|
A Achat |
Annas Christopher J. Chairman & CEO Administrateur exécutif |
1 500
+0.4%
8,9913 485 USD |
1 500 +0.4% | 8,99 | 13 485 USD | |
2024-05-03 | 2024-05-02 |
Arcutis Biotherapeutics Inc
(ARQT)
|
VP Vente planifiée |
Watanabe Todd Franklin See Remarks Administrateur exécutif |
13 783
-1.6%
8,74120 433 USD |
13 783 -1.6% | 8,74 | 120 433 USD | |
2024-05-03 | 2024-05-02 |
Edgewise Therapeutics Inc
(EWTX)
|
V Vente |
Donovan Joanne M. CMO Dirigeant |
3 682
-15.6%
18,9169 627 USD |
3 682 -15.6% | 18,91 | 69 627 USD | |
2024-05-03 | 2024-05-02 |
CCFNB Bancorp Inc
(CCFN)
|
A Achat |
Arnold Jeffrey Thomas SEVP, Finance & Risk Mgmt Dirigeant |
191
+9.4%
31,005 921 USD |
191 +9.4% | 31,00 | 5 921 USD | |
2024-05-03 | 2024-05-02 |
First National Corp
(FXNC)
|
A Achat |
Holt George Edwin III Administrateur non-exécutif |
597
+1.6%
14,758 806 USD |
597 +1.6% | 14,75 | 8 806 USD | |
2024-05-03 | 2024-05-02 |
Accolade Inc
(ACCD)
|
V Vente |
McHugh Colin Chief Accounting Officer Dirigeant |
424
-1.1%
7,283 087 USD |
424 -1.1% | 7,28 | 3 087 USD | |
2024-05-03 | 2024-05-02 |
Edgewise Therapeutics Inc
(EWTX)
|
V Vente |
MOORE JOHN R General Counsel Dirigeant |
1 956
-37.6%
18,9136 988 USD |
1 956 -37.6% | 18,91 | 36 988 USD | |
2024-05-03 | 2024-05-02 |
Precision BioSciences Inc
(DTIL)
|
VP Vente planifiée |
List Alan Chief Medical Officer Dirigeant |
290
-6.1%
10,322 993 USD |
290 -6.1% | 10,32 | 2 993 USD | |
2024-05-03 | 2024-05-02 |
RENN Fund Inc
(RCG)
|
A Achat |
STAHL MURRAY President and CEO Administrateur exécutif |
24
+0.0%
1,6740 USD |
24 +0.0% | 1,67 | 40 USD | |
2024-05-03 | 2024-05-02 |
RENN Fund Inc
(RCG)
|
A Achat |
STAHL MURRAY President and CEO Administrateur exécutif |
24
+0.0%
1,6740 USD |
24 +0.0% | 1,67 | 40 USD | |
2024-05-03 | 2024-05-02 |
RENN Fund Inc
(RCG)
|
A Achat |
STAHL MURRAY President and CEO Administrateur exécutif |
6
+0.0%
1,6710 USD |
6 +0.0% | 1,67 | 10 USD | |
2024-05-03 | 2024-05-02 |
RENN Fund Inc
(RCG)
|
A Achat |
STAHL MURRAY President and CEO Administrateur exécutif |
4
+0.1%
1,677 USD |
4 +0.1% | 1,67 | 7 USD | |
2024-05-03 | 2024-05-02 |
Carvana Co
(CVNA)
|
V Vente |
HUSTON BENJAMIN E. Chief Operating Officer Dirigeant |
200
-0.1%
118,3523 670 USD |
200 -0.1% | 118,35 | 23 670 USD | |
2024-05-03 | 2024-05-02 |
Carvana Co
(CVNA)
|
V Vente |
HUSTON BENJAMIN E. Chief Operating Officer Dirigeant |
1 329
-0.6%
117,64156 344 USD |
1 329 -0.6% | 117,64 | 156 344 USD | |
2024-05-03 | 2024-05-02 |
Carvana Co
(CVNA)
|
V Vente |
HUSTON BENJAMIN E. Chief Operating Officer Dirigeant |
2 600
-1.2%
116,35302 510 USD |
2 600 -1.2% | 116,35 | 302 510 USD | |
2024-05-03 | 2024-05-02 |
Carvana Co
(CVNA)
|
V Vente |
HUSTON BENJAMIN E. Chief Operating Officer Dirigeant |
5 689
-2.5%
115,51657 136 USD |
5 689 -2.5% | 115,51 | 657 136 USD | |
2024-05-03 | 2024-05-02 |
Carvana Co
(CVNA)
|
V Vente |
HUSTON BENJAMIN E. Chief Operating Officer Dirigeant |
4 112
-1.8%
114,47470 701 USD |
4 112 -1.8% | 114,47 | 470 701 USD | |
2024-05-03 | 2024-05-02 |
Carvana Co
(CVNA)
|
V Vente |
HUSTON BENJAMIN E. Chief Operating Officer Dirigeant |
3 500
-1.5%
113,42396 970 USD |
3 500 -1.5% | 113,42 | 396 970 USD | |
2024-05-03 | 2024-05-02 |
Carvana Co
(CVNA)
|
V Vente |
HUSTON BENJAMIN E. Chief Operating Officer Dirigeant |
570
-0.2%
112,1563 926 USD |
570 -0.2% | 112,15 | 63 926 USD | |
2024-05-03 | 2024-05-02 |
Leggett & Platt Inc
(LEG)
|
A Achat |
KLEIBOEKER RYAN MICHAEL EVP-Chief Strategic Plan. Off. Dirigeant |
10 000
+31.7%
13,39133 900 USD |
10 000 +31.7% | 13,39 | 133 900 USD | |
2024-05-03 | 2024-05-02 |
Travelers Companies Inc
(TRV)
|
V Vente |
Toczydlowski Gregory C EVP & President, Business Ins. Dirigeant |
9 372
-33.7%
214,922 014 215 USD |
9 372 -33.7% | 214,92 | 2 014 215 USD | |
2024-05-03 | 2024-05-02 |
Travelers Companies Inc
(TRV)
|
V Vente |
Toczydlowski Gregory C EVP & President, Business Ins. Dirigeant |
9 372
-33.7%
214,922 014 215 USD |
9 372 -33.7% | 214,92 | 2 014 215 USD | |
2024-05-03 | 2024-05-02 |
Aerovate Therapeutics Inc
(AVTE)
|
VP Vente planifiée |
Verwijs Marinus CHIEF TECHNICAL OFFICER Dirigeant |
1 981
-100.0%
21,0241 631 USD |
1 981 -100.0% | 21,02 | 41 631 USD | |
2024-05-03 | 2024-05-02 |
Aerovate Therapeutics Inc
(AVTE)
|
VP Vente planifiée |
Verwijs Marinus CHIEF TECHNICAL OFFICER Dirigeant |
1 981
-100.0%
21,0241 631 USD |
1 981 -100.0% | 21,02 | 41 631 USD | |
2024-05-03 | 2024-05-02 |
Transmedics Group Inc
(TMDX)
|
V Vente |
Hassanein Waleed H President & CEO Administrateur exécutif |
82
-0.1%
122,6710 059 USD |
82 -0.1% | 122,67 | 10 059 USD | |
2024-05-03 | 2024-05-02 |
Transmedics Group Inc
(TMDX)
|
V Vente |
Hassanein Waleed H President & CEO Administrateur exécutif |
82
-0.1%
122,6710 059 USD |
82 -0.1% | 122,67 | 10 059 USD | |
2024-05-03 | 2024-05-02 |
Transmedics Group Inc
(TMDX)
|
V Vente |
Hassanein Waleed H President & CEO Administrateur exécutif |
6 222
-9.2%
122,16760 080 USD |
6 222 -9.2% | 122,16 | 760 080 USD | |
2024-05-03 | 2024-05-02 |
Transmedics Group Inc
(TMDX)
|
V Vente |
Hassanein Waleed H President & CEO Administrateur exécutif |
6 222
-9.2%
122,16760 080 USD |
6 222 -9.2% | 122,16 | 760 080 USD | |
2024-05-03 | 2024-05-02 |
Transmedics Group Inc
(TMDX)
|
V Vente |
Hassanein Waleed H President & CEO Administrateur exécutif |
6 140
-8.3%
120,64740 730 USD |
6 140 -8.3% | 120,64 | 740 730 USD | |
2024-05-03 | 2024-05-02 |
Transmedics Group Inc
(TMDX)
|
V Vente |
Hassanein Waleed H President & CEO Administrateur exécutif |
6 140
-8.3%
120,64740 730 USD |
6 140 -8.3% | 120,64 | 740 730 USD | |
2024-05-03 | 2024-05-02 |
Precision BioSciences Inc
(DTIL)
|
VP Vente planifiée |
Scimeca Dario General Counsel and Secretary Dirigeant |
272
-4.6%
10,322 807 USD |
272 -4.6% | 10,32 | 2 807 USD | |
2024-05-03 | 2024-05-02 |
Precision BioSciences Inc
(DTIL)
|
VP Vente planifiée |
Scimeca Dario General Counsel and Secretary Dirigeant |
272
-4.6%
10,322 807 USD |
272 -4.6% | 10,32 | 2 807 USD | |
2024-05-03 | 2024-05-02 | V Vente |
Saba Capital Management, L.P. Actionnaire important |
13 455
-0.2%
21,28286 322 USD |
13 455 -0.2% | 21,28 | 286 322 USD | ||
2024-05-03 | 2024-05-02 | V Vente |
Saba Capital Management, L.P. Actionnaire important |
13 455
-0.2%
21,28286 322 USD |
13 455 -0.2% | 21,28 | 286 322 USD | ||
2024-05-03 | 2024-05-02 |
Equitable Holdings Inc
(EQH)
|
V Vente |
BERNSTEIN SETH P See Remarks Dirigeant |
152 473
-63.2%
38,065 802 650 USD |
152 473 -63.2% | 38,06 | 5 802 650 USD | |
2024-05-03 | 2024-05-02 |
Toast Inc
(TOST)
|
V Vente |
Gomez Elena Chief Financial Officer Dirigeant |
2 041
-1.1%
22,9646 861 USD |
2 041 -1.1% | 22,96 | 46 861 USD | |
2024-05-03 | 2024-05-02 |
Exponent Inc
(EXPO)
|
V Vente |
James Bradley A Group Vice President Dirigeant |
13
-0.1%
93,001 209 USD |
13 -0.1% | 93,00 | 1 209 USD | |
2024-05-03 | 2024-05-02 |
Anterix Inc
(ATEX)
|
VP Vente planifiée |
Gray Timothy Chief Financial Officer Dirigeant |
16 667
-15.6%
31,91531 844 USD |
16 667 -15.6% | 31,91 | 531 844 USD | |
2024-05-03 | 2024-05-02 |
Anterix Inc
(ATEX)
|
VP Vente planifiée |
Gray Timothy Chief Financial Officer Dirigeant |
16 667
-15.6%
31,91531 844 USD |
16 667 -15.6% | 31,91 | 531 844 USD | |
2024-05-03 | 2024-05-02 |
Carvana Co
(CVNA)
|
VP Vente planifiée |
GILL DANIEL J. Chief Product Officer Dirigeant |
10 000
-2.4%
120,001 200 000 USD |
10 000 -2.4% | 120,00 | 1 200 000 USD | |
2024-05-03 | 2024-05-02 |
Carvana Co
(CVNA)
|
VP Vente planifiée |
GILL DANIEL J. Chief Product Officer Dirigeant |
10 000
-2.4%
120,001 200 000 USD |
10 000 -2.4% | 120,00 | 1 200 000 USD | |
2024-05-03 | 2024-05-02 |
Carvana Co
(CVNA)
|
V Vente |
GILL DANIEL J. Chief Product Officer Dirigeant |
3 001
-0.7%
117,64353 038 USD |
3 001 -0.7% | 117,64 | 353 038 USD | |
2024-05-03 | 2024-05-02 |
Carvana Co
(CVNA)
|
V Vente |
GILL DANIEL J. Chief Product Officer Dirigeant |
3 001
-0.7%
117,64353 038 USD |
3 001 -0.7% | 117,64 | 353 038 USD | |
2024-05-03 | 2024-05-02 |
Carvana Co
(CVNA)
|
V Vente |
GILL DANIEL J. Chief Product Officer Dirigeant |
8 696
-2.0%
116,441 012 562 USD |
8 696 -2.0% | 116,44 | 1 012 562 USD | |
2024-05-03 | 2024-05-02 |
Carvana Co
(CVNA)
|
V Vente |
GILL DANIEL J. Chief Product Officer Dirigeant |
8 696
-2.0%
116,441 012 562 USD |
8 696 -2.0% | 116,44 | 1 012 562 USD | |
2024-05-03 | 2024-05-02 |
Carvana Co
(CVNA)
|
V Vente |
GILL DANIEL J. Chief Product Officer Dirigeant |
4 900
-1.1%
115,51565 999 USD |
4 900 -1.1% | 115,51 | 565 999 USD | |
2024-05-03 | 2024-05-02 |
Carvana Co
(CVNA)
|
V Vente |
GILL DANIEL J. Chief Product Officer Dirigeant |
4 900
-1.1%
115,51565 999 USD |
4 900 -1.1% | 115,51 | 565 999 USD | |
2024-05-03 | 2024-05-02 |
Carvana Co
(CVNA)
|
V Vente |
GILL DANIEL J. Chief Product Officer Dirigeant |
1 800
-0.4%
114,42205 956 USD |
1 800 -0.4% | 114,42 | 205 956 USD | |
2024-05-03 | 2024-05-02 |
Carvana Co
(CVNA)
|
V Vente |
GILL DANIEL J. Chief Product Officer Dirigeant |
1 800
-0.4%
114,42205 956 USD |
1 800 -0.4% | 114,42 | 205 956 USD | |
2024-05-03 | 2024-05-02 |
Carvana Co
(CVNA)
|
V Vente |
GILL DANIEL J. Chief Product Officer Dirigeant |
1 003
-0.2%
113,52113 861 USD |
1 003 -0.2% | 113,52 | 113 861 USD | |
2024-05-03 | 2024-05-02 |
Carvana Co
(CVNA)
|
V Vente |
GILL DANIEL J. Chief Product Officer Dirigeant |
1 003
-0.2%
113,52113 861 USD |
1 003 -0.2% | 113,52 | 113 861 USD | |
2024-05-03 | 2024-05-02 |
Carvana Co
(CVNA)
|
V Vente |
GILL DANIEL J. Chief Product Officer Dirigeant |
300
-0.1%
112,1333 639 USD |
300 -0.1% | 112,13 | 33 639 USD | |
2024-05-03 | 2024-05-02 |
BCB Bancorp Inc
(BCBP)
|
A Achat |
Garcia David Roque Chief Lending Officer Dirigeant |
1 700
+inf%
9,5916 303 USD |
1 700 +inf% | 9,59 | 16 303 USD | |
2024-05-03 | 2024-05-02 |
BCB Bancorp Inc
(BCBP)
|
A Achat |
Garcia David Roque Chief Lending Officer Dirigeant |
1 700
+inf%
9,5916 303 USD |
1 700 +inf% | 9,59 | 16 303 USD | |
2024-05-03 | 2024-05-02 |
Edgewise Therapeutics Inc
(EWTX)
|
V Vente |
Russell Alan J Chief Scientific Officer Administrateur exécutif |
1 576
-17.9%
18,9129 802 USD |
1 576 -17.9% | 18,91 | 29 802 USD | |
2024-05-03 | 2024-05-02 |
TriMas Corp
(TRS)
|
A Achat |
Parker Herbert K Administrateur non-exécutif |
1 500
+5.0%
26,3139 468 USD |
1 500 +5.0% | 26,31 | 39 468 USD | |
2024-05-03 | 2024-05-02 |
TriMas Corp
(TRS)
|
A Achat |
Parker Herbert K Administrateur non-exécutif |
1 500
+5.0%
26,3139 468 USD |
1 500 +5.0% | 26,31 | 39 468 USD | |
2024-05-03 | 2024-05-02 |
MSA Safety Inc
(MSA)
|
V Vente |
Vartanian Nishan J. CEO Administrateur exécutif |
11 000
-16.2%
185,292 038 146 USD |
11 000 -16.2% | 185,29 | 2 038 146 USD | |
2024-05-03 | 2024-05-02 |
MSA Safety Inc
(MSA)
|
V Vente |
Vartanian Nishan J. CEO Administrateur exécutif |
11 000
-16.2%
185,292 038 146 USD |
11 000 -16.2% | 185,29 | 2 038 146 USD | |
2024-05-03 | 2024-05-02 |
Northfield Bancorp Inc
(NFBK)
|
A Achat |
Harrison Timothy C Administrateur non-exécutif |
1 290
+1.9%
8,8911 468 USD |
1 290 +1.9% | 8,89 | 11 468 USD | |
2024-05-03 | 2024-05-02 |
Hims & Hers Health Inc
(HIMS)
|
VP Vente planifiée |
Baird Melissa Chief Operating Officer Dirigeant |
6 714
-1.2%
12,0881 098 USD |
6 714 -1.2% | 12,08 | 81 098 USD | |
2024-05-03 | 2024-05-02 |
Hims & Hers Health Inc
(HIMS)
|
VP Vente planifiée |
Baird Melissa Chief Operating Officer Dirigeant |
6 714
-1.2%
12,0881 098 USD |
6 714 -1.2% | 12,08 | 81 098 USD | |
2024-05-03 | 2024-05-02 |
Hims & Hers Health Inc
(HIMS)
|
VP Vente planifiée |
Baird Melissa Chief Operating Officer Dirigeant |
5 036
-0.9%
12,0860 825 USD |
5 036 -0.9% | 12,08 | 60 825 USD | |
2024-05-03 | 2024-05-02 |
Hims & Hers Health Inc
(HIMS)
|
VP Vente planifiée |
Baird Melissa Chief Operating Officer Dirigeant |
5 036
-0.9%
12,0860 825 USD |
5 036 -0.9% | 12,08 | 60 825 USD | |
2024-05-03 | 2024-05-02 |
Willdan Group Inc
(WLDN)
|
V Vente |
Forager Fund, L.P. Actionnaire important |
20 675
-1.2%
28,52589 655 USD |
20 675 -1.2% | 28,52 | 589 655 USD | |
2024-05-03 | 2024-05-02 |
Willdan Group Inc
(WLDN)
|
V Vente |
Forager Fund, L.P. Actionnaire important |
20 675
-1.2%
28,52589 655 USD |
20 675 -1.2% | 28,52 | 589 655 USD | |
2024-05-03 | 2024-05-02 | VP Vente planifiée |
Bender Jeremy CHIEF EXECUTIVE OFFICER Administrateur exécutif |
6
-0.0%
17,94108 USD |
6 -0.0% | 17,94 | 108 USD | ||
2024-05-03 | 2024-05-02 |
Xencor Inc
(XNCR)
|
V Vente |
Valente Nancy EVP, Chief Development Officer Dirigeant |
4 745
-7.9%
23,58111 872 USD |
4 745 -7.9% | 23,58 | 111 872 USD | |
2024-05-03 | 2024-05-02 |
Columbia Sportswear Co
(COLM)
|
V Vente |
SIMMONS SABRINA Administrateur non-exécutif |
523
-7.5%
81,7042 729 USD |
523 -7.5% | 81,70 | 42 729 USD | |
2024-05-03 | 2024-05-02 |
City Holding Co
(CHCO)
|
V Vente |
LEGGE JEFFREY DALE EVP, CAO & CIO Dirigeant |
2 500
-25.8%
105,02262 557 USD |
2 500 -25.8% | 105,02 | 262 557 USD | |
2024-05-03 | 2024-05-02 |
ACADIA Pharmaceuticals Inc
(ACAD)
|
VP Vente planifiée |
Kihara James PRINCIPAL ACCOUNTING OFFICER Dirigeant |
1 326
-8.4%
16,9422 462 USD |
1 326 -8.4% | 16,94 | 22 462 USD |